+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Amniotic Membrane Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 201 Pages
  • March 2022
  • Region: Global
  • Allied Analytics LLP
  • ID: 5578243
UP TO OFF until Aug 20th 2022
The global amniotic membrane market was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.



Amniotic membrane is the inmost layer of the placenta, which includes a thick basement membrane or a tissue and an avascular stromal matrix. This membrane has the ability to promote healing; thus, it is utilized in surgical procedures related to Genito-urinary tract, skin, brain, and head and neck. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, as well as corneal disorders with associated limbal stem cell deficiency.

The major factors that drive the growth of the global amniotic membrane market include rise in amniotic membrane transplantation and rise in awareness and education about the benefits of amniotic membrane transplantation. In addition, technological innovations to develop cost-effective therapies are expected to lead to a paradigm shift in the amniotic membrane market globally. However, lack of healthcare professionals restricts the market growth.

The global amniotic membrane market is segmented on the basis of type of product, application, end user and region. According to product type, the market is divided into cryopreserved amniotic membrane and lyophilization amniotic membrane. On the basis of applications, the market is divided into surgical wounds, ophthalmology, and others. On the basis of end user, the market is divided into hospitals, ambulatory surgical centers, specialized clinics, and research center & laboratories. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).

The major companies profiled in the report include AlloSure, Inc., Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc, Skye Biologics Inc., and TissueTech, Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets
  • Comprehensive analysis of factors that drive and restrict the market growth is provided detailed quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities
  • Extensive analysis of the key segments of the industry helps understand the type of products and applications used globally
  • Key market players and their strategies are provided to understand the competitive outlook of the market

By Product

  • Cryopreserved Amniotic Membrane
  • Lyophilization Amniotic Membrane

By Application

  • Surgical Wounds
  • Ophthalmology
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Research Centers & laboratories

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY PLAYERS

  • Allosure, Inc
  • Amnio Technology, LLC
  • Applied Biologics LLC
  • FzioMed, Inc
  • Human Regenerative Technologies, LLC
  • Integra Lifesciences Holdings Corporation
  • Corza Ophthalmology
  • MiMedx Group, Inc
  • Skye Biologics Inc
  • TissueTech, Inc
Frequently Asked Questions about the Global Amniotic Membrane Market

What is the estimated value of the Global Amniotic Membrane Market?

The Global Amniotic Membrane Market was estimated to be valued at $1102.5 million in 2020.

What is the growth rate of the Global Amniotic Membrane Market?

The growth rate of the Global Amniotic Membrane Market is 4.6%, with an estimated value of $1728.1 million by 2030.

What is the forecasted size of the Global Amniotic Membrane Market?

The Global Amniotic Membrane Market is estimated to be worth $1728.1 million by 2030.

Who are the key companies in the Global Amniotic Membrane Market?

Key companies in the Global Amniotic Membrane Market include Allosure, Inc, Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc, Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc. and TissueTech, Inc..

Table of Contents

Chapter 1: Introduction
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Covid-19 Impact Analysis
Chapter 4: Amniotic Membrane Market, by Product Type
4.1. Market Overview
4.1.1Market Size and Forecast, by Product Type
4.2. Cryopreserved Amniotic Membrane
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.3. Lyophilization Amniotic Membrane
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
Chapter 5: Amniotic Membrane Market, by Application
5.1. Market Overview
5.1.1Market Size and Forecast, by Application
5.2. Surgical Wound
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, by Region
5.2.3. Market Share Analysis, by Country
5.3. Opthalomology
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, by Region
5.3.3. Market Share Analysis, by Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, by Region
5.4.3. Market Share Analysis, by Country
Chapter 6: Amniotic Membrane Market, by End-user
6.1. Market Overview
6.1.1Market Size and Forecast, by End-user
6.2. Hospital
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, by Region
6.2.3. Market Share Analysis, by Country
6.3. Ambulatory Surgical Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, by Region
6.3.3. Market Share Analysis, by Country
6.4. Specialized Clinics
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, by Region
6.4.3. Market Share Analysis, by Country
6.5. Research Center and Labs
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, by Region
6.5.3. Market Share Analysis, by Country
Chapter 7: Amniotic Membrane Market, by Region
7.1. Market Overview
7.1.1Market Size and Forecast, by Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, by Product Type
7.2.3. Market Size and Forecast, by Application
7.2.4. Market Size and Forecast, by End-user
7.2.5. Market Size and Forecast, by Country
7.2.6. U. S. Amniotic Membrane Market
7.2.6.1. Market Size and Forecast, by Product Type
7.2.6.2. Market Size and Forecast, by Application
7.2.6.3. Market Size and Forecast, by End-user
7.2.7. Canada Amniotic Membrane Market
7.2.7.1. Market Size and Forecast, by Product Type
7.2.7.2. Market Size and Forecast, by Application
7.2.7.3. Market Size and Forecast, by End-user
7.2.8. Mexico Amniotic Membrane Market
7.2.8.1. Market Size and Forecast, by Product Type
7.2.8.2. Market Size and Forecast, by Application
7.2.8.3. Market Size and Forecast, by End-user
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, by Product Type
7.3.3. Market Size and Forecast, by Application
7.3.4. Market Size and Forecast, by End-user
7.3.5. Market Size and Forecast, by Country
7.3.6. Germany Amniotic Membrane Market
7.3.6.1. Market Size and Forecast, by Product Type
7.3.6.2. Market Size and Forecast, by Application
7.3.6.3. Market Size and Forecast, by End-user
7.3.7. France Amniotic Membrane Market
7.3.7.1. Market Size and Forecast, by Product Type
7.3.7.2. Market Size and Forecast, by Application
7.3.7.3. Market Size and Forecast, by End-user
7.3.8. UK Amniotic Membrane Market
7.3.8.1. Market Size and Forecast, by Product Type
7.3.8.2. Market Size and Forecast, by Application
7.3.8.3. Market Size and Forecast, by End-user
7.3.9. Italy Amniotic Membrane Market
7.3.9.1. Market Size and Forecast, by Product Type
7.3.9.2. Market Size and Forecast, by Application
7.3.9.3. Market Size and Forecast, by End-user
7.3.10. Spain Amniotic Membrane Market
7.3.10.1. Market Size and Forecast, by Product Type
7.3.10.2. Market Size and Forecast, by Application
7.3.10.3. Market Size and Forecast, by End-user
7.3.11. Rest of Europe Amniotic Membrane Market
7.3.11.1. Market Size and Forecast, by Product Type
7.3.11.2. Market Size and Forecast, by Application
7.3.11.3. Market Size and Forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, by Product Type
7.4.3. Market Size and Forecast, by Application
7.4.4. Market Size and Forecast, by End-user
7.4.5. Market Size and Forecast, by Country
7.4.6. Japan Amniotic Membrane Market
7.4.6.1. Market Size and Forecast, by Product Type
7.4.6.2. Market Size and Forecast, by Application
7.4.6.3. Market Size and Forecast, by End-user
7.4.7. China Amniotic Membrane Market
7.4.7.1. Market Size and Forecast, by Product Type
7.4.7.2. Market Size and Forecast, by Application
7.4.7.3. Market Size and Forecast, by End-user
7.4.8. Australia Amniotic Membrane Market
7.4.8.1. Market Size and Forecast, by Product Type
7.4.8.2. Market Size and Forecast, by Application
7.4.8.3. Market Size and Forecast, by End-user
7.4.9. India Amniotic Membrane Market
7.4.9.1. Market Size and Forecast, by Product Type
7.4.9.2. Market Size and Forecast, by Application
7.4.9.3. Market Size and Forecast, by End-user
7.4.10. South Korea Amniotic Membrane Market
7.4.10.1. Market Size and Forecast, by Product Type
7.4.10.2. Market Size and Forecast, by Application
7.4.10.3. Market Size and Forecast, by End-user
7.4.11. Rest of Asia-Pacific Amniotic Membrane Market
7.4.11.1. Market Size and Forecast, by Product Type
7.4.11.2. Market Size and Forecast, by Application
7.4.11.3. Market Size and Forecast, by End-user
7.5. Lamea
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, by Product Type
7.5.3. Market Size and Forecast, by Application
7.5.4. Market Size and Forecast, by End-user
7.5.5. Market Size and Forecast, by Country
7.5.6. Brazil Amniotic Membrane Market
7.5.6.1. Market Size and Forecast, by Product Type
7.5.6.2. Market Size and Forecast, by Application
7.5.6.3. Market Size and Forecast, by End-user
7.5.7. South Africa, Amniotic Membrane Market
7.5.7.1. Market Size and Forecast, by Product Type
7.5.7.2. Market Size and Forecast, by Application
7.5.7.3. Market Size and Forecast, by End-user
7.5.8. Saudi Arabia Amniotic Membrane Market
7.5.8.1. Market Size and Forecast, by Product Type
7.5.8.2. Market Size and Forecast, by Application
7.5.8.3. Market Size and Forecast, by End-user
7.5.9. Rest of LAMEA Amniotic Membrane Market
7.5.9.1. Market Size and Forecast, by Product Type
7.5.9.2. Market Size and Forecast, by Application
7.5.9.3. Market Size and Forecast, by End-user
Chapter 8: Company Profiles
8.1. Allosure, Inc
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Amnio Technology, LLC
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Applied Biologics LLC
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Fziomed Inc
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Human Regenerative Technologies, LLC
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Integra Lifesciences Holdings Corporation
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Katena, Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Mimedx Group Inc
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Skye Biologics Inc
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Tissue-Tech Inc
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
List of Tables
Table 1. Global Amniotic Membrane Market, by Product Type, 2020-2030 ($Million)
Table 2. Global Amniotic Membrane Market for Cryopreserved Amniotic Membrane, by Region, 2020-2030 ($Million)
Table 3. Global Amniotic Membrane Market for Lyophilization Amniotic Membrane, by Region, 2020-2030 ($Million)
Table 4. Global Amniotic Membrane Market, by Application, 2020-2030 ($Million)
Table 5. Global Amniotic Membrane Market for Surgical Wound, by Region, 2020-2030 ($Million)
Table 6. Global Amniotic Membrane Market for Opthalomology, by Region, 2020-2030 ($Million)
Table 7. Global Amniotic Membrane Market for Others, by Region, 2020-2030 ($Million)
Table 8. Global Amniotic Membrane Market, by End-user, 2020-2030 ($Million)
Table 9. Global Amniotic Membrane Market for Hospital, by Region, 2020-2030 ($Million)
Table 10. Global Amniotic Membrane Market for Ambulatory Surgical Centers, by Region, 2020-2030 ($Million)
Table 11. Global Amniotic Membrane Market for Specialized Clinics, by Region, 2020-2030 ($Million)
Table 12. Global Amniotic Membrane Market for Research Center and Labs, by Region, 2020-2030 ($Million)
Table 13. Global Amniotic Membrane Market, by Region, 2020-2030 ($Million)
Table 14. North America Amniotic Membrane, by Region, 2020-2030 ($Million)
Table 15. North America Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 16. North America Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 17. North America Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 18. U.S Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 19. U.S Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 20. U.S Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 21. Canada Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 22. Canada Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 23. Canada Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 24. Mexico Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 25. Mexico Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 26. Mexico Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 27. Europe Amniotic Membrane, by Region, 2020-2030 ($Million)
Table 28. Europe Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 29. Europe Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 30. Europe Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 31. Germany Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 32. Germany Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 33. Germany Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 34. France Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 35. France Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 36. France Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 37. Uk Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 38. Uk Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 39. Uk Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 40. Italy Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 41. Italy Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 42. Italy Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 43. Spain Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 44. Spain Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 45. Spain Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 46. Rest of Europe Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 47. Rest of Europe Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 48. Rest of Europe Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 49. Asia-Pacific Amniotic Membrane, by Region, 2020-2030 ($Million)
Table 50. Asia-Pacific Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 51. Asia-Pacific Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 52. Asia-Pacific Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 53. Japan Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 54. Japan Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 55. Japan Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 56. China Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 57. China Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 58. China Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 59. Australia Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 60. Australia Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 61. Australia Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 62. India Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 63. India Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 64. India Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 65. South Korea Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 66. South Korea Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 67. South Korea Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 68. Rest of Asia-Pacific Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 69. Rest of Asia-Pacific Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 70. Rest of Asia-Pacific Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 71. Lamea Amniotic Membrane, by Region, 2020-2030 ($Million)
Table 72. Lamea Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 73. Lamea Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 74. Lamea Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 75. Brazil Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 76. Brazil Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 77. Brazil Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 78. South Africa, Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 79. South Africa, Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 80. South Africa, Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 81. Saudi Arabia Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 82. Saudi Arabia Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 83. Saudi Arabia Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 84. Rest of LAMEA Amniotic Membrane, by Product Type, 2020-2030 ($Million)
Table 85. Rest of LAMEA Amniotic Membrane, by Application, 2020-2030 ($Million)
Table 86. Rest of LAMEA Amniotic Membrane, by End-user, 2020-2030 ($Million)
Table 87. Allosure, Inc Inc: Key Executives
Table 88. Allosure, Inc Inc: Company Snapshot
Table 89. Allosure, Inc Inc: Operating Segments
Table 90. Allosure, Inc Inc: Product Portfolio
Table 91. Allosure, Inc Inc: Key Strategic Moves and Developments
Table 92. Amnio Technology, LLC: Key Executives
Table 93. Amnio Technology, LLC: Company Snapshot
Table 94. Amnio Technology, LLC: Operating Segments
Table 95. Amnio Technology, LLC: Product Portfolio
Table 96. Amnio Technology, LLC: Key Strategic Moves and Developments
Table 97. Applied Biologics LLC: Key Executives
Table 98. Applied Biologics LLC: Company Snapshot
Table 99. Applied Biologics LLC: Operating Segments
Table 100. Applied Biologics LLC: Product Portfolio
Table 101. Applied Biologics LLC: Key Strategic Moves and Developments
Table 102. Fziomed Inc: Key Executives
Table 103. Fziomed Inc: Company Snapshot
Table 104. Fziomed Inc: Operating Segments
Table 105. Fziomed Inc: Product Portfolio
Table 106. Fziomed Inc: Key Strategic Moves and Developments
Table 107. Human Regenerative Technologies, LLC: Key Executives
Table 108. Human Regenerative Technologies, LLC: Company Snapshot
Table 109. Human Regenerative Technologies, LLC: Operating Segments
Table 110. Human Regenerative Technologies, LLC: Product Portfolio
Table 111. Human Regenerative Technologies, LLC: Key Strategic Moves and Developments
Table 112. Integra Lifesciences Holdings Corporation: Key Executives
Table 113. Integra Lifesciences Holdings Corporation: Company Snapshot
Table 114. Integra Lifesciences Holdings Corporation: Operating Segments
Table 115. Integra Lifesciences Holdings Corporation: Product Portfolio
Table 116. Integra Lifesciences Holdings Corporation: Key Strategic Moves and Developments
Table 117. Katena, Inc. : Key Executives
Table 118. Katena, Inc. : Company Snapshot
Table 119. Katena, Inc. : Operating Segments
Table 120. Katena, Inc. : Product Portfolio
Table 121. Katena, Inc. : Key Strategic Moves and Developments
Table 122. Mimedx Group Inc: Key Executives
Table 123. Mimedx Group Inc: Company Snapshot
Table 124. Mimedx Group Inc: Operating Segments
Table 125. Mimedx Group Inc: Product Portfolio
Table 126. Mimedx Group Inc: Key Strategic Moves and Developments
Table 127. Skye Biologics Inc: Key Executives
Table 128. Skye Biologics Inc: Company Snapshot
Table 129. Skye Biologics Inc: Operating Segments
Table 130. Skye Biologics Inc: Product Portfolio
Table 131. Skye Biologics Inc: Key Strategic Moves and Developments
Table 132. Tissue-Tech Inc: Key Executives
Table 133. Tissue-Tech Inc: Company Snapshot
Table 134. Tissue-Tech Inc: Operating Segments
Table 135. Tissue-Tech Inc: Product Portfolio
Table 136. Tissue-Tech Inc: Key Strategic Moves and Developments
List of Figures
Figure 1. Global Amniotic Membrane Market Segmentation
Figure 2. Global Amniotic Membrane Market
Figure 3. Segmentation Amniotic Membrane Market
Figure 4. Top Investment Pocket in Amniotic Membrane Market
Figure 5. Top Winning Strategies, 2019-2021*
Figure 6. Top Winning Strategies, by Development, 2019-2021(%)
Figure 7. Top Winning Strategies, by Company, 2019-2021*
Figure 8. Moderate Bargaining Power of Buyers
Figure 9. Moderate Bargaining Power of Suppliers
Figure 10. Moderate Threat of New Entrants
Figure 11. Low Threat of Substitution
Figure 12. High Competitive Rivalry
Figure 13. Top Player Positioning, 2020
Figure 14. Market Share Analysis, 2020
Figure 15. Restraints and Drivers: Amniotic Membrane Market
Figure 16. Amniotic Membrane Market Segmentation, by Product Type
Figure 17. Amniotic Membrane Market for Cryopreserved Amniotic Membrane, by Country, 2020-2030 ($ Million)
Figure 18. Amniotic Membrane Market for Lyophilization Amniotic Membrane, by Country, 2020-2030 ($ Million)
Figure 19. Amniotic Membrane Market Segmentation, by Application
Figure 20. Amniotic Membrane Market for Surgical Wound, by Country, 2020-2030 ($ Million)
Figure 21. Amniotic Membrane Market for Opthalomology, by Country, 2020-2030 ($ Million)
Figure 22. Amniotic Membrane Market for Others, by Country, 2020-2030 ($ Million)
Figure 23. Amniotic Membrane Market Segmentation, by End-user
Figure 24. Amniotic Membrane Market for Hospital, by Country, 2020-2030 ($ Million)
Figure 25. Amniotic Membrane Market for Ambulatory Surgical Centers, by Country, 2020-2030 ($ Million)
Figure 26. Amniotic Membrane Market for Specialized Clinics, by Country, 2020-2030 ($ Million)
Figure 27. Amniotic Membrane Market for Research Center and Labs, by Country, 2020-2030 ($ Million)
Figure 28. Allosure, Inc Inc: Net Sales, 2018-2020 ($ Million)
Figure 29. Allosure, Inc Inc: Revenue Share, by Segment, 2020 (%)
Figure 30. Allosure, Inc Inc: Revenue Share, by Region, 2020 (%)
Figure 31. Amnio Technology, LLC: Net Sales, 2018-2020 ($ Million)
Figure 32. Amnio Technology, LLC: Revenue Share, by Segment, 2020 (%)
Figure 33. Amnio Technology, LLC: Revenue Share, by Region, 2020 (%)
Figure 34. Applied Biologics LLC: Net Sales, 2018-2020 ($ Million)
Figure 35. Applied Biologics LLC: Revenue Share, by Segment, 2020 (%)
Figure 36. Applied Biologics LLC: Revenue Share, by Region, 2020 (%)
Figure 37. Fziomed Inc: Net Sales, 2018-2020 ($ Million)
Figure 38. Fziomed Inc: Revenue Share, by Segment, 2020 (%)
Figure 39. Fziomed Inc: Revenue Share, by Region, 2020 (%)
Figure 40. Human Regenerative Technologies, LLC: Net Sales, 2018-2020 ($ Million)
Figure 41. Human Regenerative Technologies, LLC: Revenue Share, by Segment, 2020 (%)
Figure 42. Human Regenerative Technologies, LLC: Revenue Share, by Region, 2020 (%)
Figure 43. Integra Lifesciences Holdings Corporation: Net Sales, 2018-2020 ($ Million)
Figure 44. Integra Lifesciences Holdings Corporation: Revenue Share, by Segment, 2020 (%)
Figure 45. Integra Lifesciences Holdings Corporation: Revenue Share, by Region, 2020 (%)
Figure 46. Katena, Inc: Net Sales, 2018-2020 ($ Million)
Figure 47. Katena, Inc: Revenue Share, by Segment, 2020 (%)
Figure 48. Katena, Inc: Revenue Share, by Region, 2020 (%)
Figure 49. Mimedx Group Inc: Net Sales, 2018-2020 ($ Million)
Figure 50. Mimedx Group Inc: Revenue Share, by Segment, 2020 (%)
Figure 51. Mimedx Group Inc: Revenue Share, by Region, 2020 (%)
Figure 52. Skye Biologics Inc: Net Sales, 2018-2020 ($ Million)
Figure 53. Skye Biologics Inc: Revenue Share, by Segment, 2020 (%)
Figure 54. Skye Biologics Inc: Revenue Share, by Region, 2020 (%)
Figure 55. Tissue-Tech Inc: Net Sales, 2018-2020 ($ Million)
Figure 56. Tissue-Tech Inc: Revenue Share, by Segment, 2020 (%)
Figure 57. Tissue-Tech Inc: Revenue Share, by Region, 2020 (%)

Executive Summary

According to a new report titled, “Amniotic Membrane Market by Product Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030,” The global amniotic membrane market size was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.

Amniotic membrane is the innermost layer forming the fetal membranes. It is used as a graft or as a dressing in different surgical subspecialties. In the field of ophthalmology, this tissue is used as a tissue bandage for cornea infections and sterile melts, and to reconstruct the ocular surface for various procedures. In addition, this membrane protects and stimulates the repair of injured tissues via paracrine actions and also acts as a vector for bio-delivery of exogenous factors to treat injury and ailments. Also, the anti-inflammatory property of transplanted amniotic membrane is used as therapy against chronic inflammation in geriatric population. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, a corneal disorders with associated limbal stem cell deficiency.

Increase in the rapid expansion of the geriatric population and increase in adoption of amniotic membrane for varied applications are expected to drive the market growth. In addition, technological innovations to develop cost-effective therapies are expected to lead to a paradigm shift in the amniotic membrane market, globally. However, lack of healthcare professionals is expected to impede the market growth.

On the basis of product type, the global amniotic membrane market is categorized as cryopreserved amniotic membrane and lyophilization amniotic membrane. Lcryopreserved amniotic membrane is expected to dominate the market during the forecast period as this membrane can be stored at ambient temperatures for prolonged periods. Lyophilization amniotic membrane is expected to register a CAGR of 5.2% during the forecast period. Increase in awareness among patients towards the diagnosis and treatment options for amniotic membrane transplantation is expected to increase the growth of the market. Moreover, several pharmaceutical companies focus on developing products for the amniotic membrane transplantation, which is expected to drive the growth of the market during the forecast period.

On the basis of application, the surgical wound segment accounted for a major share of the market in the global amniotic membrane market in 2020. Owing to the rise in number of chronic and infectious diseases, a global rise in the number of surgeries has been witnessed that boosts the market potential. In addition, the ophthalmology segment is expected to register a CAGR of 4.9% during the forecast period. This segment is expected to exhibit a prominent growth rate, owing to the utilization of amniotic membrane, which leads to faster recovery of various eye-associated ailments.

On the basis of end user, the hospitals segment presently dominates the market, and is expected to remain dominant during the forecast period, due to frequent visits by patients, as hospitals are the primary care settings facilitating easy treatment for a wide range of diseases. The rise in usage of amniotic membranes in ASCs is another factor that is expected to enhance the market growth. The use of these products is easy and effective and also facilitates recovery of the wound without frequent visits to hospitals or clinics, which further drives the growth of market.

North America accounted for more than 40% of the global market share in 2020, and is expected to remain dominant during the forecast period. This was attributed to the well-established healthcare system and increase in adoption of amniotic membrane transplantation for varied applications, increase in number of geriatric patients, and supportive reimbursement policies in the healthcare system. Asia-Pacific is projected to register the highest CAGR of 5.9% during the forecast period. Rise in disposable income and presence of large geriatric population in developing countries are expected to drive the growth of amniotic membrane market in the region. In addition, increase in healthcare expenditure offers a lucrative opportunity for the market growth.

The major companies profiled in the report include AlloSource, Inc, Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc, Skye Biologics Inc., and TissueTech, Inc.

Key Findings Of Study


  • The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets
  • Comprehensive analysis of factors that drive and restrict the amniotic membrane market growth is provided
  • A detailed quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing amniotic membrane market opportunities
  • Extensive analysis of the key segments of the industry helps understand the type of products and applications used globally
  • Key players and their strategies are provided to understand the competitive outlook of the amniotic membrane market

Companies Mentioned

  • Allosure, Inc
  • Amnio Technology, LLC
  • Applied Biologics LLC
  • FzioMed, Inc
  • Human Regenerative Technologies, LLC
  • Integra Lifesciences Holdings Corporation
  • Corza Ophthalmology
  • MiMedx Group, Inc.
  • Skye Biologics Inc.
  • TissueTech, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...